生命科学资讯

Immunoglobulin M regulates airway hyperresponsiveness independent of T helper 2 allergic inflammation

A systematic bi-genomic split-GFP assay illuminates the mitochondrial matrix proteome and protein targeting routes

Transcriptional subtypes on immune microenvironment and predicting postoperative recurrence and metastasis in human pheochromocytoma and paraganglioma

The fate of pyruvate dictates cell growth by modulating cellular redox potential

Endoscopic liquid biopsies of gastric fluid in a large human patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancer

Postural adaptations may contribute to the unique locomotor energetics seen in hopping kangaroos

Strikingly different neurotransmitter release strategies in dopaminergic subclasses

Lenz discloses case of retinal tear in presbyopia eye drop patient

FDA wants to use more real-world data and calls again for early-phase trials reform

Enhertu combo wins FDA approval for first-line use in metastatic breast cancer

Pfizer, Sanofi pull out checkbooks for separate year-end autoimmune pacts

Chai infuses AI drug discovery efforts with $130M series B

J&J-backed Link launches with $60M, plan to create next-gen CAR-T therapies

Aviceda geographic atrophy hopeful fails to top Astellas' med in phase 2

Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat

FDA speeds up review of J&J's multiple myeloma combo treatment following positive data

With GLP-1 microdoses, Noom targets lower-BMI group outside FDA obesity drug labels

Med-tech gainers and losers for Dec. 8-12, 2025

Gilead posts second Phase 3 win for new HIV-fighting drug regimen

Argenx falters in effort to expand immune drug’s use